US 2011/0236477 A1Published application

Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof

AssigneeBoehringer Ingelheim International GmbH

InventorsPeter Schneider, Wolfram Eisenreich, Nantharat Pearnchob

Life of this patent

Estimating the term…

Abstract

The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a SGLT-2 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.

Claims35

Dependent claims

A pharmaceutical composition comprising a SGLT-2 inhibitor, a partner drug, and one or more pharmaceutical excipients.

Dependencies are inferred from the claim text.

Facts

Application: 12/894,385Filed 30 Sep 2010
Priority: EP 09172081.32 Oct 2009
Published: 29 Sep 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification28 codes

A61K 9/2072
Pills, tablets, discs, rods: characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially…
A61K 9/2009
Excipients; Inactive ingredients: inorganic compounds
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2027
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates

Family

US 10,610,489 B2Related patent
US 2011/0236477 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results